Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Shanda Group has entered a period of renewed visibility, with a series of incubated ventures coming to light over the past ...

Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

AI can help design AI systems: automating architecture choices, discovering algorithms, and optimizing hardware ...

Toward the end of this decade, a choice may face the species that could reshape its interactions with intelligence itself and ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and ...

Riyadh, Saudi Arabia: Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreement with Batterjee Pharma, a leading Saudi pharmaceutical ...

Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...

Precise underwater navigation is critical for autonomous and remotely operated deep-sea vehicles, yet variations in seawater ...

Wang Zhi, dean of the School of Fine Arts, explained, "Through this theme, we aim to anchor intellectual weight in an era of technological acceleration, tracing back to the foundational logic that ...